No food competing for blood flow
Wegovy uses an active ingredient called semaglutide which only targets the GLP-1 hormone receptor
Eight weeks of supplementation (2 g/day) combined with aerobic training (3 sessions a week) had no significant effects on body weight, BMI and daily dietary intake in obese women [42]
This GLP-1 receptor agonist medication, prescribed for diabetes management and weight reduction, can influence reproductive hormones through several mechanisms
Excess adipose tissue promotes inflammation, alters hormone levels, and creates a metabolic environment associated with increased breast cancer risk, particularly after menopause
A common protocol for patients with a B12 deficiency may be 1,000 mcg daily for one week, then the same dosage once weekly, and then the same dosage once per month after the deficiency has been addressed